Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study
- 9 December 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 82 (5), 186-230
- https://doi.org/10.1016/j.jinf.2020.12.007
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
This publication has 8 references indexed in Scilit:
- Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle ThresholdsClinical Infectious Diseases, 2021
- Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care TestJournal of Clinical Microbiology, 2020
- Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assaysReproductive BioMedicine Online, 2020
- Comparison of SARS-CoV-2 detection in nasopharyngeal swab and salivaJournal of Infection, 2020
- Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal SwabsJournal of Clinical Microbiology, 2020
- Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic SamplesClinical Infectious Diseases, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020